{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:48:59Z","timestamp":1790142539755,"version":"4.0.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG12411"],"award-info":[{"award-number":["AG12411"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014190","name":"Windgate Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100014190","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ottenheimer Brothers Foundation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Philip R Jonsson Foundation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"STOP Alzheimer's","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Inglewood Foundation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Neuroinflammation, typified by elevated levels of interleukin-1 (IL-1) \u03b1 and \u03b2, and deficits in proteostasis, characterized by accumulation of polyubiquitinated proteins and other aggregates, are associated with neurodegenerative disease independently and through interactions of the two phenomena. We investigated the influence of IL-1\u03b2 on ubiquitination via its impact on activation of the E3 ligase parkin by either phosphorylated ubiquitin (P-Ub) or NEDD8.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Immunohistochemistry and Proximity Ligation Assay were used to assess colocalization of parkin with P-tau or NEDD8 in hippocampus from Alzheimer patients (AD) and controls. IL-1\u03b2 effects on PINK1, P-Ub, parkin, P-parkin, and GSK3\u03b2\u2014as well as phosphorylation of parkin by GSK3\u03b2\u2014were assessed in cell cultures by western immunoblot, using two inhibitors and siRNA knockdown to suppress GSK3\u03b2. Computer modeling characterized the binding and the effects of P-Ub and NEDD8 on parkin. IL-1\u03b1, IL-1\u03b2, and parkin gene expression was assessed by RT-PCR in brains of 2- and 17-month-old PD-APP mice and wild-type littermates.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>IL-1\u03b1, IL-1\u03b2, and parkin mRNA levels were higher in PD-APP mice compared with wild-type littermates, and IL-1\u03b1-laden glia surrounded parkin- and P-tau-laden neurons in human AD. Such neurons showed a nuclear-to-cytoplasmic translocation of NEDD8 that was mimicked in IL-1\u03b2-treated primary neuronal cultures. These cultures also showed higher parkin levels and GSK3\u03b2-induced parkin phosphorylation; PINK1 levels were suppressed. In silico simulation predicted that binding of either P-Ub or NEDD8 at a singular position on parkin opens the UBL domain, exposing Ser<jats:sub>65<\/jats:sub> for parkin activation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The promotion of parkin- and NEDD8-mediated ubiquitination by IL-1\u03b2 is consistent with an acute neuroprotective role. However, accumulations of P-tau and P-Ub and other elements of proteostasis, such as translocated NEDD8, in AD and in response to IL-1\u03b2 suggest either over-stimulation or a proteostatic failure that may result from chronic IL-1\u03b2 elevation, easily envisioned considering its early induction in Down\u2019s syndrome and mild cognitive impairment. The findings further link autophagy and neuroinflammation, two important aspects of AD pathogenesis, which have previously been only loosely related.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12974-019-1669-z","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T16:02:34Z","timestamp":1577462554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Interleukin-1\u03b2 drives NEDD8 nuclear-to-cytoplasmic translocation, fostering parkin activation via NEDD8 binding to the P-ubiquitin activating site"],"prefix":"10.1186","volume":"16","author":[{"given":"Meenakshisundaram","family":"Balasubramaniam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Parcon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chhanda","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R.","family":"Farlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Mrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven W.","family":"Barger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0405-7800","authenticated-orcid":false,"given":"W. Sue T.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,27]]},"reference":[{"issue":"9","key":"1669_CR1","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.neurobiolaging.2007.11.026","volume":"30","author":"Y Chen","year":"2009","unstructured":"Chen Y, et al. In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model. Neurobiol Aging. 2009;30(9):1453\u201365.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1669_CR2","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1073\/pnas.0908953107","volume":"107","author":"Y Jiang","year":"2010","unstructured":"Jiang Y, et al. Alzheimer\u2019s-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition. Proc Natl Acad Sci U S A. 2010;107(4):1630\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1669_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/jnen\/64.2.113","volume":"64","author":"RA Nixon","year":"2005","unstructured":"Nixon RA, et al. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol. 2005;64(2):113\u201322.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"19","key":"1669_CR4","doi-asserted-by":"publisher","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","volume":"86","author":"WS Griffin","year":"1989","unstructured":"Griffin WS, et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A. 1989;86(19):7611\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1669_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0002-9440(10)64538-5","volume":"157","author":"AM Cataldo","year":"2000","unstructured":"Cataldo AM, et al. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer\u2019s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol. 2000;157(1):277\u201386.","journal-title":"Am J Pathol"},{"issue":"27","key":"1669_CR6","doi-asserted-by":"publisher","first-page":"6926","DOI":"10.1523\/JNEUROSCI.0800-08.2008","volume":"28","author":"B Boland","year":"2008","unstructured":"Boland B, et al. Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer\u2019s disease. J Neurosci. 2008;28(27):6926\u201337.","journal-title":"J Neurosci"},{"issue":"5\u20136","key":"1669_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0197-0186(01)00041-9","volume":"39","author":"JG Sheng","year":"2001","unstructured":"Sheng JG, et al. Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer\u2019s disease: potential significance for tau protein phosphorylation. Neurochem Int. 2001;39(5\u20136):341\u20138.","journal-title":"Neurochem Int"},{"issue":"2","key":"1669_CR8","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1006\/exnr.2000.7393","volume":"163","author":"JG Sheng","year":"2000","unstructured":"Sheng JG, et al. Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo. Exp Neurol. 2000;163(2):388\u201391.","journal-title":"Exp Neurol"},{"issue":"5","key":"1669_CR9","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/0197-4580(96)00104-2","volume":"17","author":"JG Sheng","year":"1996","unstructured":"Sheng JG, et al. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol Aging. 1996;17(5):761\u20136.","journal-title":"Neurobiol Aging"},{"key":"1669_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1742-2094-3-5","volume":"3","author":"WS Griffin","year":"2006","unstructured":"Griffin WS, et al. Interleukin-1 mediates Alzheimer and Lewy body pathologies. J Neuroinflammation. 2006;3:5.","journal-title":"J Neuroinflammation"},{"issue":"105","key":"1669_CR11","first-page":"cm1","volume":"3","author":"A Weber","year":"2010","unstructured":"Weber A, Wasiliew P, Kracht M. Interleukin-1 (IL-1) pathway. Sci Signal. 2010;3(105):cm1.","journal-title":"Sci Signal"},{"issue":"6645","key":"1669_CR12","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/42257","volume":"388","author":"SW Barger","year":"1997","unstructured":"Barger SW, Harmon AD. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature. 1997;388(6645):878\u201381.","journal-title":"Nature"},{"issue":"5","key":"1669_CR13","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1523\/JNEUROSCI.23-05-01605.2003","volume":"23","author":"Y Li","year":"2003","unstructured":"Li Y, et al. Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J Neurosci. 2003;23(5):1605\u201311.","journal-title":"J Neurosci"},{"issue":"1","key":"1669_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1523\/JNEUROSCI.20-01-00149.2000","volume":"20","author":"Y Li","year":"2000","unstructured":"Li Y, et al. Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J Neurosci. 2000;20(1):149\u201355.","journal-title":"J Neurosci"},{"key":"1669_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fncel.2015.00103","volume":"9","author":"O Aboud","year":"2015","unstructured":"Aboud O, et al. Aging, Alzheimer\u2019s, and APOE genotype influence the expression and neuronal distribution patterns of microtubule motor protein dynactin-P50. Front Cell Neurosci. 2015;9:103.","journal-title":"Front Cell Neurosci"},{"issue":"1\u20132","key":"1669_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jneuroim.2003.10.043","volume":"147","author":"Y Li","year":"2004","unstructured":"Li Y, et al. Microglial activation by uptake of fDNA via a scavenger receptor. J Neuroimmunol. 2004;147(1\u20132):50\u20135.","journal-title":"J Neuroimmunol"},{"key":"1669_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.neuroscience.2016.01.035","volume":"319","author":"P Su","year":"2016","unstructured":"Su P, et al. The role of autophagy in modulation of neuroinflammation in microglia. Neuroscience. 2016;319:155\u201367.","journal-title":"Neuroscience"},{"key":"1669_CR18","doi-asserted-by":"crossref","unstructured":"Houtman J, et al. Beclin1-driven autophagy modulates the inflammatory response of microglia via NLRP3. EMBO J. 2019;38(4):1\u201315.","DOI":"10.15252\/embj.201899430"},{"issue":"4","key":"1669_CR19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1046\/j.1365-2990.1998.00122.x","volume":"24","author":"JG Sheng","year":"1998","unstructured":"Sheng JG, et al. Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer\u2019s disease. Neuropathol Appl Neurobiol. 1998;24(4):278\u201383.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"10","key":"1669_CR20","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.neurobiolaging.2004.02.027","volume":"25","author":"AM Cataldo","year":"2004","unstructured":"Cataldo AM, et al. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome. Neurobiol Aging. 2004;25(10):1263\u201372.","journal-title":"Neurobiol Aging"},{"key":"1669_CR21","first-page":"248","volume":"7","author":"CW Zhang","year":"2015","unstructured":"Zhang CW, et al. Parkin regulation and neurodegenerative disorders. Front Aging Neurosci. 2015;7:248.","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"1669_CR22","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1093\/hmg\/dds070","volume":"21","author":"YS Choo","year":"2012","unstructured":"Choo YS, et al. Regulation of parkin and PINK1 by neddylation. Hum Mol Genet. 2012;21(11):2514\u201323.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"1669_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00109-013-1112-3","volume":"92","author":"I Lonskaya","year":"2014","unstructured":"Lonskaya I, et al. Nilotinib-induced autophagic changes increase endogenous parkin level and ubiquitination, leading to amyloid clearance. J Mol Med (Berl). 2014;92(4):373\u201386.","journal-title":"J Mol Med (Berl)"},{"issue":"4","key":"1669_CR24","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/hmg\/ddt501","volume":"23","author":"X Hong","year":"2014","unstructured":"Hong X, et al. Parkin overexpression ameliorates hippocampal long-term potentiation and beta-amyloid load in an Alzheimer\u2019s disease mouse model. Hum Mol Genet. 2014;23(4):1056\u201372.","journal-title":"Hum Mol Genet"},{"key":"1669_CR25","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neuroscience.2012.12.018","volume":"232","author":"I Lonskaya","year":"2013","unstructured":"Lonskaya I, et al. Decreased parkin solubility is associated with impairment of autophagy in the nigrostriatum of sporadic Parkinson\u2019s disease. Neuroscience. 2013;232:90\u2013105.","journal-title":"Neuroscience"},{"issue":"12","key":"1669_CR26","doi-asserted-by":"publisher","first-page":"e83914","DOI":"10.1371\/journal.pone.0083914","volume":"8","author":"I Lonskaya","year":"2013","unstructured":"Lonskaya I, et al. Ubiquitination increases parkin activity to promote autophagic alpha-synuclein clearance. PLoS One. 2013;8(12):e83914.","journal-title":"PLoS One"},{"issue":"6","key":"1669_CR27","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1074\/jbc.M112.419945","volume":"288","author":"ML Hebron","year":"2013","unstructured":"Hebron ML, et al. Parkin ubiquitinates Tar-DNA binding protein-43 (TDP-43) and promotes its cytosolic accumulation via interaction with histone deacetylase 6 (HDAC6). J Biol Chem. 2013;288(6):4103\u201315.","journal-title":"J Biol Chem"},{"key":"1669_CR28","doi-asserted-by":"crossref","unstructured":"McWilliams TG, et al. Phosphorylation of Parkin at serine 65 is essential for its activation in vivo. Open Biol. 2018;8(11):1\u201318.","DOI":"10.1098\/rsob.180108"},{"issue":"7503","key":"1669_CR29","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nature13392","volume":"510","author":"F Koyano","year":"2014","unstructured":"Koyano F, et al. Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature. 2014;510(7503):162\u20136.","journal-title":"Nature"},{"issue":"7714","key":"1669_CR30","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41586-018-0224-x","volume":"559","author":"C Gladkova","year":"2018","unstructured":"Gladkova C, et al. Mechanism of parkin activation by PINK1. Nature. 2018;559(7714):410\u20134.","journal-title":"Nature"},{"issue":"3","key":"1669_CR31","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.bbrc.2008.10.104","volume":"377","author":"Y Kim","year":"2008","unstructured":"Kim Y, et al. PINK1 controls mitochondrial localization of Parkin through direct phosphorylation. Biochem Biophys Res Commun. 2008;377(3):975\u201380.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"1669_CR32","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1093\/brain\/awx258","volume":"140","author":"F Du","year":"2017","unstructured":"Du F, et al. PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer\u2019s disease. Brain. 2017;140(12):3233\u201351.","journal-title":"Brain"},{"issue":"5","key":"1669_CR33","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/jnr.22828","volume":"90","author":"JW Um","year":"2012","unstructured":"Um JW, et al. Neddylation positively regulates the ubiquitin E3 ligase activity of parkin. J Neurosci Res. 2012;90(5):1030\u201342.","journal-title":"J Neurosci Res"},{"issue":"7565","key":"1669_CR34","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature14879","volume":"524","author":"T Wauer","year":"2015","unstructured":"Wauer T, et al. Mechanism of phospho-ubiquitin-induced PARKIN activation. Nature. 2015;524(7565):370\u20134.","journal-title":"Nature"},{"issue":"3","key":"1669_CR35","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1128\/MCB.00775-14","volume":"35","author":"JA Segovia","year":"2015","unstructured":"Segovia JA, et al. Nedd8 regulates inflammasome-dependent caspase-1 activation. Mol Cell Biol. 2015;35(3):582\u201397.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"1669_CR36","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.bbrc.2016.11.084","volume":"482","author":"F Yan","year":"2017","unstructured":"Yan F, et al. MyD88 NEDDylation negatively regulates MyD88-dependent NF-kappaB signaling through antagonizing its ubiquitination. Biochem Biophys Res Commun. 2017;482(4):632\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"1669_CR37","doi-asserted-by":"publisher","first-page":"L1070","DOI":"10.1152\/ajplung.00349.2018","volume":"316","author":"R Hao","year":"2019","unstructured":"Hao R, et al. MLN4924 protects against interleukin-17A-induced pulmonary inflammation by disrupting ACT1-mediated signaling. Am J Physiol Lung Cell Mol Physiol. 2019;316(6):L1070\u201380.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"48","key":"1669_CR38","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.1038\/sj.onc.1203093","volume":"18","author":"T Hori","year":"1999","unstructured":"Hori T, et al. Covalent modification of all members of human cullin family proteins by NEDD8. Oncogene. 1999;18(48):6829\u201334.","journal-title":"Oncogene"},{"issue":"4","key":"1669_CR39","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1083\/jcb.200104035","volume":"155","author":"K Tateishi","year":"2001","unstructured":"Tateishi K, et al. The NEDD8 system is essential for cell cycle progression and morphogenetic pathway in mice. J Cell Biol. 2001;155(4):571\u20139.","journal-title":"J Cell Biol"},{"issue":"1","key":"1669_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1083\/jcb.200304003","volume":"163","author":"Y Chen","year":"2003","unstructured":"Chen Y, et al. APP-BP1 mediates APP-induced apoptosis and DNA synthesis and is increased in Alzheimer\u2019s disease brain. J Cell Biol. 2003;163(1):27\u201333.","journal-title":"J Cell Biol"},{"issue":"11","key":"1669_CR41","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1111\/j.1582-4934.2012.01604.x","volume":"16","author":"Y Chen","year":"2012","unstructured":"Chen Y, Neve RL, Liu H. Neddylation dysfunction in Alzheimer\u2019s disease. J Cell Mol Med. 2012;16(11):2583\u201391.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1669_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1365-2990.2004.00603.x","volume":"31","author":"F Mori","year":"2005","unstructured":"Mori F, et al. Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders. Neuropathol Appl Neurobiol. 2005;31(1):53\u201361.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"1669_CR43","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, et al. The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology. 1991;41(4):479\u201386.","journal-title":"Neurology"},{"issue":"3","key":"1669_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","volume":"16","author":"H Braak","year":"1995","unstructured":"Braak H, Braak E. Staging of Alzheimer\u2019s disease-related neurofibrillary changes. Neurobiol Aging. 1995;16(3):271\u20138 discussion 278-84.","journal-title":"Neurobiol Aging"},{"issue":"6514","key":"1669_CR45","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/373523a0","volume":"373","author":"D Games","year":"1995","unstructured":"Games D, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature. 1995;373(6514):523\u20137.","journal-title":"Nature"},{"issue":"3","key":"1669_CR46","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1471-4159.2004.02909.x","volume":"92","author":"L Liu","year":"2005","unstructured":"Liu L, et al. S100B-induced microglial and neuronal IL-1 expression is mediated by cell type-specific transcription factors. J Neurochem. 2005;92(3):546\u201353.","journal-title":"J Neurochem"},{"issue":"8","key":"1669_CR47","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/NEN.0b013e318180ec47","volume":"67","author":"SW Barger","year":"2008","unstructured":"Barger SW, et al. Relationships between expression of apolipoprotein E and beta-amyloid precursor protein are altered in proximity to Alzheimer beta-amyloid plaques: potential explanations from cell culture studies. J Neuropathol Exp Neurol. 2008;67(8):773\u201383.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"1669_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004578","volume":"11","author":"S Lovera","year":"2015","unstructured":"Lovera S, et al. Towards a molecular understanding of the link between imatinib resistance and kinase conformational dynamics. PLoS Comput Biol. 2015;11(11):e1004578.","journal-title":"PLoS Comput Biol"},{"issue":"18","key":"1669_CR49","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1523\/JNEUROSCI.16-18-05795.1996","volume":"16","author":"E Masliah","year":"1996","unstructured":"Masliah E, et al. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer\u2019s disease. J Neurosci. 1996;16(18):5795\u2013811.","journal-title":"J Neurosci"},{"issue":"2","key":"1669_CR50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.17925\/USN.2010.06.02.19","volume":"6","author":"WS Griffin","year":"2010","unstructured":"Griffin WS, Barger SW. Neuroinflammatory cytokines-the common thread in Alzheimer\u2019s pathogenesis. US Neurol. 2010;6(2):19\u201327.","journal-title":"US Neurol"},{"issue":"5","key":"1669_CR51","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1046\/j.1471-4159.1994.63051872.x","volume":"63","author":"JG Sheng","year":"1994","unstructured":"Sheng JG, et al. Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity. J Neurochem. 1994;63(5):1872\u20139.","journal-title":"J Neurochem"},{"key":"1669_CR52","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/1742-2094-8-175","volume":"8","author":"L Liu","year":"2011","unstructured":"Liu L, et al. Apolipoprotein E expression is elevated by interleukin 1 and other interleukin 1-induced factors. J Neuroinflammation. 2011;8:175.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"1669_CR53","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1750-3639.1998.tb00136.x","volume":"8","author":"WS Griffin","year":"1998","unstructured":"Griffin WS, et al. Glial-neuronal interactions in Alzheimer\u2019s disease: the potential role of a \u2018cytokine cycle\u2019 in disease progression. Brain Pathol. 1998;8(1):65\u201372.","journal-title":"Brain Pathol"},{"issue":"8","key":"1669_CR54","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nm.3232","volume":"19","author":"RA Nixon","year":"2013","unstructured":"Nixon RA. The role of autophagy in neurodegenerative disease. Nat Med. 2013;19(8):983\u201397.","journal-title":"Nat Med"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-019-1669-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-019-1669-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-019-1669-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,26]],"date-time":"2020-12-26T00:24:38Z","timestamp":1608942278000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-019-1669-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1669"],"URL":"https:\/\/doi.org\/10.1186\/s12974-019-1669-z","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"15 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Human tissues used for this study were collected at autopsy for reasons other than for this study and were judged as exempt from Federal regulations on human subjects via exemption 4, with Human Subject Assurance Number 00001119 by the University of Arkansas for Medical Sciences Institutional Review Board. Animal studies were carried out in strict accordance with the recommendations of US National Institutes of Health Guide for the Care and Use of Laboratory Animals. The protocol was approved by the Institutional Animal Care and Use Committee (IACUC approval number: a3063-01). All efforts were made to minimize pain and suffering.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"275"}}